Small anti-herpes RNA molecules applied to the vagina protect mice against new herpes simplex virus type 2 (HSV-2) infections for one week.
Small anti-herpes RNA molecules applied to the vagina protect mice against new herpes simplex virus type 2 (HSV-2) infections for one week.